Genome-based mining of new antimicrobial meroterpenoids from the phytopathogenic fungus Bipolaris sorokiniana strain 11134

Jianying Han,Jingyu Zhang,Zhijun Song,Guoliang Zhu,Miaomiao Liu,Huanqin Dai,Tom Hsiang,Xueting Liu,Lixin Zhang,Ronald J Quinn,Yunjiang Feng
DOI: https://doi.org/10.1007/s00253-020-10522-1
IF: 5
2020-03-26
Applied Microbiology and Biotechnology
Abstract:Polyketide–terpenoid hybrid compounds are one of the largest families of meroterpenoids, with great potential for drug development for resistant pathogens. Genome sequence analysis of secondary metabolite gene clusters of a phytopathogenic fungus, <i>Bipolaris sorokiniana</i> 11134, revealed a type I polyketide gene cluster, consisting of highly reducing polyketide synthase, non-reducing polyketide synthase, and adjacent prenyltransferase. MS- and UV-guided isolations led to the isolation of ten meroterpenoids, including two new compounds: 19-dehydroxyl-3-<i>epi</i>-arthripenoid A (<b>1</b>) and 12-keto-cochlioquinone A (<b>2</b>). The structures of <b>1</b>–<b>10</b> were elucidated by the analysis of NMR and high-resolution electrospray ionization mass spectroscopy data. Compounds <b>5</b>–<b>8</b> and <b>10</b> showed moderate activity against common <i>Staphylococcus aureus</i> and methicillin-resistant <i>S. aureus</i>, with minimum inhibitory concentration (MIC) values of 12.5–100 μg/mL. Compound <b>5</b> also exhibited activity against four clinical resistant <i>S. aureus</i> strains and synergistic antifungal activity against <i>Candida albicans</i> with MIC values of 12.5–25 μg/mL. The biosynthetic gene cluster of the isolated compounds and their putative biosynthetic pathway are also proposed.
biotechnology & applied microbiology
What problem does this paper attempt to address?